NobleBlocks

Research indexJournal article

Современные подходы к доклинической оценке безопасности лекарственных средств растительного происхождения

Крепкова

Биомедицина1 Jan 2011

Abstract

Cancer is one of the most dreaded diseases with a complex pathogenesis, which threats human life greatly. Multidisciplinary scientific investigations are making best efforts to combat this disease and put to the identification of novel anticancer agents. Patent anticancer agents registered in China are therefore increasing dramatically during the past ten years, which will be reviewed briefly in this article. platinum complexes anthracycline analogs (including doxorubicin derivatives) quinoline analogs podophyllotoxins analogs taxane analogs camptothecin (CPT) analogs.

Discussion

Citations

Topics

More

Suggest a correction or report